Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019

Abstract The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in HIV-1 subtype variability across Poland between 2015 and 2019. Sequences of the pol...

Full description

Bibliographic Details
Main Authors: Karol Serwin, Anna Urbańska, Kaja Scheibe, Magdalena Witak-Jędra, Maria Jankowska, Maria Hlebowicz, Monika Bociąga-Jasik, Anna Kalinowska-Nowak, Martyna Biała, Hubert Ciepłucha, Władysław Łojewski, Anita Olczak, Elżbieta Jabłonowska, Aldona Kowalczuk-Kot, Błażej Rozpłochowski, Adam Witor, Miłosz Parczewski
Format: Article
Language:English
Published: Nature Publishing Group 2021-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-96125-w
id doaj-57ebb405ba7b40c8803ef69e003bae93
record_format Article
spelling doaj-57ebb405ba7b40c8803ef69e003bae932021-08-22T11:24:16ZengNature Publishing GroupScientific Reports2045-23222021-08-0111111710.1038/s41598-021-96125-wMolecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019Karol Serwin0Anna Urbańska1Kaja Scheibe2Magdalena Witak-Jędra3Maria Jankowska4Maria Hlebowicz5Monika Bociąga-Jasik6Anna Kalinowska-Nowak7Martyna Biała8Hubert Ciepłucha9Władysław Łojewski10Anita Olczak11Elżbieta Jabłonowska12Aldona Kowalczuk-Kot13Błażej Rozpłochowski14Adam Witor15Miłosz Parczewski16Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in SzczecinDepartment of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in SzczecinDepartment of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in SzczecinDepartment of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in SzczecinPomeranian Center for Infectious Diseases and TuberculosisPomeranian HospitalDepartment of Infectious and Tropical Diseases, Jagiellonian University Medical CollegeDepartment of Infectious and Tropical Diseases, Jagiellonian University Medical CollegeDepartment of Infectious Diseases, Liver Disease and Acquired Immune Deficiencies, Wroclaw Medical UniversityDepartment of Infectious Diseases, Liver Disease and Acquired Immune Deficiencies, Wroclaw Medical UniversityDepartment of Infectious Diseases, Regional Hospital in Zielona GoraDepartment of Infectious Diseases and Hepatology, Faculty of Medicine, Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum in BydgoszczDepartment of Infectious Diseases and Hepatology, Medical University of ŁódźDepartment of Infectious Diseases, Medical University of BiałystokDepartment of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Karol Marcinkowski University of Medical SciencesRegional Hospital, Out-Patient’s Clinic for Immune DeficiencyDepartment of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in SzczecinAbstract The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in HIV-1 subtype variability across Poland between 2015 and 2019. Sequences of the pol gene fragment from 2518 individuals were used for the analysis of subtype prevalence. Subtype B was dominant (n = 2163, 85.90%). The proportion of subtype B-infected individuals decreased significantly, from 89.3% in 2015 to 80.3% in 2019. This was related to the increasing number of subtype A infections. In 355 (14.10%) sequences, non-B variants were identified. In 65 (2.58%) samples, recombinant forms (RFs) were noted. Unique recombinant forms (URFs) were found in 30 (1.19%) sequences. Three A/B recombinant clusters were identified of which two were A6/B mosaic viruses not previously described. Non-B clades were significantly more common among females (n = 81, 22.8%, p = 0.001) and heterosexually infected individuals (n = 45, 32.4%, p = 0.0031). The predominance of subtype B is evident, but the variability of HIV-1 in Poland is notable. Almost half of RFs (n = 65, 2.58%) was comprised of URFs (n = 30, 1.19%); thus those forms were common in the analyzed population. Hence, molecular surveillance of identified variants ensures recognition of HIV-1 evolution in Poland.https://doi.org/10.1038/s41598-021-96125-w
collection DOAJ
language English
format Article
sources DOAJ
author Karol Serwin
Anna Urbańska
Kaja Scheibe
Magdalena Witak-Jędra
Maria Jankowska
Maria Hlebowicz
Monika Bociąga-Jasik
Anna Kalinowska-Nowak
Martyna Biała
Hubert Ciepłucha
Władysław Łojewski
Anita Olczak
Elżbieta Jabłonowska
Aldona Kowalczuk-Kot
Błażej Rozpłochowski
Adam Witor
Miłosz Parczewski
spellingShingle Karol Serwin
Anna Urbańska
Kaja Scheibe
Magdalena Witak-Jędra
Maria Jankowska
Maria Hlebowicz
Monika Bociąga-Jasik
Anna Kalinowska-Nowak
Martyna Biała
Hubert Ciepłucha
Władysław Łojewski
Anita Olczak
Elżbieta Jabłonowska
Aldona Kowalczuk-Kot
Błażej Rozpłochowski
Adam Witor
Miłosz Parczewski
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
Scientific Reports
author_facet Karol Serwin
Anna Urbańska
Kaja Scheibe
Magdalena Witak-Jędra
Maria Jankowska
Maria Hlebowicz
Monika Bociąga-Jasik
Anna Kalinowska-Nowak
Martyna Biała
Hubert Ciepłucha
Władysław Łojewski
Anita Olczak
Elżbieta Jabłonowska
Aldona Kowalczuk-Kot
Błażej Rozpłochowski
Adam Witor
Miłosz Parczewski
author_sort Karol Serwin
title Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
title_short Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
title_full Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
title_fullStr Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
title_full_unstemmed Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
title_sort molecular epidemiology and hiv-1 variant evolution in poland between 2015 and 2019
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-08-01
description Abstract The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in HIV-1 subtype variability across Poland between 2015 and 2019. Sequences of the pol gene fragment from 2518 individuals were used for the analysis of subtype prevalence. Subtype B was dominant (n = 2163, 85.90%). The proportion of subtype B-infected individuals decreased significantly, from 89.3% in 2015 to 80.3% in 2019. This was related to the increasing number of subtype A infections. In 355 (14.10%) sequences, non-B variants were identified. In 65 (2.58%) samples, recombinant forms (RFs) were noted. Unique recombinant forms (URFs) were found in 30 (1.19%) sequences. Three A/B recombinant clusters were identified of which two were A6/B mosaic viruses not previously described. Non-B clades were significantly more common among females (n = 81, 22.8%, p = 0.001) and heterosexually infected individuals (n = 45, 32.4%, p = 0.0031). The predominance of subtype B is evident, but the variability of HIV-1 in Poland is notable. Almost half of RFs (n = 65, 2.58%) was comprised of URFs (n = 30, 1.19%); thus those forms were common in the analyzed population. Hence, molecular surveillance of identified variants ensures recognition of HIV-1 evolution in Poland.
url https://doi.org/10.1038/s41598-021-96125-w
work_keys_str_mv AT karolserwin molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT annaurbanska molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT kajascheibe molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT magdalenawitakjedra molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT mariajankowska molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT mariahlebowicz molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT monikabociagajasik molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT annakalinowskanowak molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT martynabiała molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT hubertciepłucha molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT władysławłojewski molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT anitaolczak molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT elzbietajabłonowska molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT aldonakowalczukkot molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT błazejrozpłochowski molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT adamwitor molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
AT miłoszparczewski molecularepidemiologyandhiv1variantevolutioninpolandbetween2015and2019
_version_ 1721199747242393600